Helixmith Mods Engensis Trial Plans As Probe Unravels PK Anomalies

Pushing Ahead With Phase III Gene Therapy Program

Gene therapy
Clinical Operation Issues Caused PK Flaws In Helixmith Trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia